Contact Us

Chicago Pradaxa Attorney of Phillips Law Offices Alerts Clients of Recently Created Multidistrict Litigation in Southern District of Illinois

Personal injury attorney Stephen D. Phillips of Phillips Law Offices reports that the U.S. Judicial Panel on Multidistrict Litigation has ordered a consolidation of all federally filed Pradaxa lawsuits.
  • <strong>Chicago attorney Stephen D. Phillips of Phillips Law Offices represents injured Pradaxa victims</strong>
    CHICAGO, IL, August 24, 2012 /24-7PressRelease/ -- On August 8, 2012, the U.S. Judicial Panel on Multidistrict Litigation (JPML) entered an order that would consolidate all current and future federally filed Pradaxa lawsuits (MDL No. 2385). The JPML selected Judge David R. Herndon, chief judge of the Southern District of Illinois, as the presiding judge.

Pradaxa litigation attorney Stephen D. Phillips, of Phillips Law Offices, explained that because so many cases have been filed over the drug's adverse effects (21 currently), centralization of the suits will make litigation more efficient and fair. It will eliminate duplicate discovery, prevent inconsistencies, and allow plaintiffs and their representatives to pool their resources.

The JPML selected Illinois for the litigation as it is a central and convenient location for both plaintiffs and defense nationwide.

Personal injury attorney Phillips stated, "With Chicago lawyers taking leading roles in the consolidated actions nationwide, it is no surprise that the JPML is recognizing the Southern District of Illinois as a practical forum for expeditious and fair pretrial proceedings and discovery."

Pradaxa is produced by the pharmaceutical company Boehringer Ingelheim and approved by the FDA in late 2010. The drug is meant to treat patients with the heart condition atrial fibrillation, and prescribed to prevent blood clots that can lead to strokes or heart attacks. The drug was produced to replace Warfarin, an older blood thinner. Both Warfarin and Pradaxa are known to cause hemorrhages. However, hemorrhaging on Warfarin can be stopped with Vitamin K. There is no reversal agent for hemorrhaging on Pradaxa.

Attorney Phillips urges anyone affected by Pradaxa to consult with his offices. The product litigation attorneys at Phillips Law Offices have a great deal of experience with Pradaxa cases, and are ready to answer any questions the public may have about this drug and its complications, Phillips said.

About Phillips Law Offices

For more than 65 years, the Chicago injury attorneys of Phillips Law Offices have been protecting Illinois individuals and families from the negligent acts of medical and pharmaceutical professionals who put everyone's life and health in danger by their careless actions.

Founding partner Stephen D. Phillips and his colleagues represent clients who have lost a child, spouse, sibling, or parent, or who are personally victimized because of pharmaceutical injuries, physician malpractice, automobile accidents, boating accidents, trucking accidents, traumatic brain injuries, hospital negligence, mesothelioma and defective products.

For more information about the firm, please visit the Phillips Law website http://www.phillipslawoffices.com or call 312-346-4262.

Phillips Law Offices
http://maps.google.com/maps/place?cid=5991762937128771800 [161 N. Clark St., Suite 4925, Chicago, IL 60601-3296 __title__ Chicago Personal Injury Law Firm] (312) 346-4262


# # #



Comment on this story...

Share This Story


Email this Story

Contact Information


Stephen Phillips
Phillips Law Offices

Chicago, IL
USA
Voice: 312-346-4262
E-Mail: Email Us Here
Website: Visit Our Website

Like This Story?


I like it! 0

Disclaimer


If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release Newswire. We are unable to assist you with any information regarding this release. 24-7 Press Release Newswire disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.